INTRODUCTION
============

Development requires coordination between molecular patterning and morphogenesis ([@R1], [@R2]). Several studies suggest how morphogens can drive gene patterning, growth, and shape generation in different systems ([@R3], [@R4]) and how mechanical constraints might feedback on growth ([@R5], [@R6]). Although adaptation to size is often seen in developmental tissues ([@R1], [@R7]), how tissue geometry and size feedback on gene expression domains is less understood. Using a combination of computational and experimental approaches, we address this question in the shoot apical meristem (SAM), the stem cell niche source of all aboveground plant organs ([@R8]).

Considered as a main orchestrator of the SAM activity ([@R9], [@R10]), *WUSCHEL* (*WUS*) is expressed in a central domain, a few cell layers below the apex of the SAM. It encodes a transcription factor, moving between cells, and is involved in perpetuating stem cell activity and keeping differentiating cells at bay ([@R11], [@R12]). At the very tip of the SAM, the stem cells express the CLAVATA3 peptide (CLV3) that diffuses in the tissue and down-regulates *WUS*, closing the canonical CLV3/WUS feedback loop ([@R13], [@R14]), thought to be the main factor maintaining SAM homeostasis. On the flanks of the meristem, WUS also represses the differentiation program including the *KANADI1* (*KAN1*) marker ([@R12]). Spatial aspects of *WUS* maintenance via cytokinin signaling have recently been elucidated: LONELY GUY (LOG) proteins, which catalyze cytokinin biosynthesis, are expressed in the epidermis (L1), and ARABIDOPSIS HISTIDINE KINASE (AHK) cytokinin receptors are expressed inside the tissue, a few cell layers away from the L1 ([@R15], [@R16]) ([Fig. 1A](#F1){ref-type="fig"}). Along with previously published data ([@R17], [@R18]), this implies that the epidermis may provide a major positional cue for SAM maintenance.

![The epidermis-driven model reproduces the wild-type gene expression patterns.\
(**A**) Expression domains of cytokinin receptors (*AHK2*, *AHK3*, *AHK4*), and cytokinin-activating enzymes (*LOG4*, *LOG7*) in green (fluorescent protein markers, Supplementary Materials) together with plasma membranes in red (FM4-64 dye). Scale bars, 20 μm. (**B**) Representation of the model. Solid lines indicate interactions supported by molecular evidence, whereas dashed lines show interactions supported by indirect evidence. (**C**) Optimized domains of *WUS*, *CLV3*, and *KAN1* in two-dimensional (2D) (left) and 3D (right) abstract representations of the tissue. Gene expression intensity is color-coded. (**D**) Optimized domains of *CLV3* and *WUS* in a segmented tissue obtained from confocal microscopy. Gene expression domains from the simulation are shown in green, and plasma membranes are shown in red (FM4-64 dye). The diffusive signal concentrations are displayed with the color map of (C) (minimum, blue, to maximum, red). Model equations are defined in the Supplementary Materials, and model parameter values are given in table S1.](1500989-F1){#F1}

RESULTS AND DISCUSSION
======================

To investigate this hypothesis, we propose an integrated quantitative description of the processes regulating the SAM homeostasis where the L1 is central to the patterning of the stem cell regulatory genes ([Fig. 1B](#F1){ref-type="fig"}). The spatial model integrates the SAM regulatory interactions described in a system of differential equations, using Hill formalism for transcription together with mass action and passive diffusion-like transport (Supplementary Materials) ([@R11], [@R12], [@R19]). It includes the CLV3/WUS feedback loop and the repression of *KAN1* by WUS. In particular, the L1 produces four signals modeled as diffusive molecules. Of those, cytokinin acts as an activator of *WUS* by binding the AHK receptors. Given the expression pattern of the *AHK*s ([Fig. 1A](#F1){ref-type="fig"}), we hypothesized a repressive L1 signal, keeping the AHKs away from the epidermis (termed AHK-). Cytokinin and AHK- form an incoherent feed-forward motif regulating *WUS* ([@R20]) ([Fig. 1](#F1){ref-type="fig"}, A and B). Two additional signals produced by the epidermis also activate *CLV3* ([@R11], [@R12], [@R19]) and *KAN1* ([@R12]).

Different representations of the meristematic tissue are used throughout this study. Two abstract tissue templates, one 2D and one 3D, are composed of overlapping spherical cells constrained in a parabolic shape ([Fig. 1C](#F1){ref-type="fig"} and fig. S1). A realistic tissue template obtained from segmented confocal data ([@R20]) is also used and includes cell volumes and cell contact surfaces ([Fig. 1D](#F1){ref-type="fig"}). For all these templates, the bottom layer of cells implements a specific boundary condition (referred to as sink), abstracting the diffusion of molecules outside of the meristem and into the tissues below (stem and vasculature), where molecules are removed from simulations based on their diffusion rate. As such, the faster a molecule diffuses in the meristematic tissue, the faster it is carried out of the system at the bottom boundary. In contrast, epidermal cells have a nonflux boundary to the outside of the tissue.

Model parameters are optimized to obtain the wild-type expression domains of *WUS*, *CLV3*, and *KAN1* using a dedicated strategy based on the Covariance Matrix Adaptation Evolution Strategy (CMA-ES) algorithm ([@R21]) (Supplementary Materials and fig. S2). At equilibrium, the model achieves a correct representation of the expression domains showing that the epidermis-driven model is sufficient for SAM patterning. This result is robust in the different representations of the meristematic tissue ([Fig. 1](#F1){ref-type="fig"}, C and D). The model is also able to qualitatively reproduce a large set of experimentally observed perturbations including perturbations of the *CLV3/WUS* feedback loop and perturbations of cytokinin signaling (Supplementary Materials and fig. S3).

Several mutants of *Arabidopsis thaliana* result in meristematic tissue defects ([@R12], [@R22]--[@R24]); an example is the *clavata* phenotype, causing plants with markedly enlarged and flattened meristems. In such tissues, the *CLV3* domain forms a band a few cell layers thick capping the SAM, whereas *WUS* is expressed in another band-like domain below *CLV3* ([@R23]) ([Fig. 2A](#F2){ref-type="fig"}). Simulating *clavata* in the wild-type tissue geometry results in a limited enlargement of the *CLV3* and *WUS* domains, as experimentally shown upon inducing the mutation: the first 24 hours shows an expansion of the *CLV3* domain via dedifferentiation of a few cells, later leading to increased growth and major reorganization ([@R25]). When applied to an enlarged and flattened meristem, the model shows a substantial reorganization of the *CLV3* and *WUS* domains in two superposed bands ([Fig. 2A](#F2){ref-type="fig"}). This stresses the importance of geometrical changes to explain the shift in expression domains and is in strong agreement with experimental data. The *pCLV3::WUS* misexpression line ([@R23]) is another reproducible example of extreme geometrical rearrangement, resulting in both *CLV3* and *WUS* overlapping in the external cell layers of a massively enlarged meristem (fig. S4).

![*WUS* and *CLV3* expression domains respond to the geometry of the meristem.\
(**A**) From left to right: In situ hybridizations of *WUS* and *CLV3* in wild-type meristems and their simulated counterparts, *clavata* phenotype simulated in a wild-type 2D meristem and in a geometry mimicking the enlarged tissue observed in mutant plants, and in situ hybridizations of *WUS* and *CLV3* in *clv1* loss of function meristems. Scale bars, 50 μm. (**B**) Expression domains of *WUS* and *CLV3* for various meristem sizes. From top to bottom: *WUS* expression experimentally observed (lateral section and top projection) and simulated, and *CLV3* expression experimentally observed and simulated. LD indicates plants grown under long-day conditions; SD-LD indicates growth in short days followed by long days. Scale bars, 20 μm. (B) shows representative examples of meristems presented in (C). (**C**) Correlation between meristem sizes and gene expression domain sizes: left, experimental data (from top projections); right, simulations (domain size is the number of expressing cells). Values obtained from linear regression are given for the experimental data (slope, interception, and *P* value; see the Supplementary Materials). Data for individual conditions are provided in figs. S5 and S6.](1500989-F2){#F2}

Wild-type meristems also show size variations, but contrary to the aforementioned mutants, the regulatory network is unaffected. To test the specific effect of geometry, we thus applied the model on tissue templates of various sizes. The simulations predict a robust positive correlation across optimized parameter sets between the size of *WUS* and *CLV3* domains, measured by the number of expressing cells and the size of the tissue templates ([Fig. 2](#F2){ref-type="fig"}, B and C, and Supplementary Materials). Hence, the model predicts an adaptive scaling behavior of the stem cell regulatory expression domains to the meristem size. We tested this hypothesis by growing different *A. thaliana* genotypes in different environmental conditions, resulting in a set of plants with various inflorescence SAM sizes (ranging from 5000 to 20,000 μm^2^ and from 5000 to 13,000 μm^2^ for *pWUS* \>\> *GFP* and *pCLV3* \>\> *GFP* plants, respectively). Measured on top projections ([Fig. 2B](#F2){ref-type="fig"} and Supplementary Materials), the area of the *WUS* domains ranged from 700 to 5000 μm^2^, and the size of the *CLV3* domains ranged from 1000 to 3000 μm^2^, in both cases showing a significant correlation with the size of the tissue (linear regression *P* values \<10^−3^), confirming the predicted adaptive scaling mechanism of the key regulatory components of stem cell regulation ([Fig. 2C](#F2){ref-type="fig"}). Strikingly, tissue size variations seen in individual genotypes and growth conditions also correlate to the domain sizes (figs. S5 and S6). As opposed to the classical homeostatic view on the SAM domains, this result shows a built-in adaptability of the stem cell pool to changes in tissue size.

Next, we quantified the shape of the meristematic tissue across the data set (Supplementary Materials, [Fig. 3](#F3){ref-type="fig"}, and figs. S7 to S19). We parameterized the surface of the meristems by parabolic functions. Notably, the curvature varies across samples, and this correlates with the shape of both *pWUS* \>\> *GFP* ([Fig. 3](#F3){ref-type="fig"}, A, B, and D, and figs. S8 and S13) and *pCLV3* \>\> *GFP* (figs. S7, A and B, and S14 to S19) expression domains; the flatter the tissue, the more laterally elongated are the domains. Simulating the model on a collection of tissue templates reproducing this geometrical variability shows that the model also captures this effect ([Fig. 3C](#F3){ref-type="fig"} and figs. S7C and S20). Hence, the proposed regulatory network adapts the domains not only to the size of the tissue but also to its shape. Note that we observe a correlation between our size and shape measures (fig. S21), showing that larger meristems are also flatter.

![WUS expression domain is elongated for flatter meristems.\
(**A**) Meristem and expression domain shapes. The *x* axis is the value of the *a* parameter of the parabola outlying the meristem; the higher the value, the flatter the meristem (see the Supplementary Materials). The *y* axis is the ratio between the longest vertical axis of *pWUS* \>\> *GFP* expression domain and its longest horizontal axis; the higher the value, the more horizontally elongated the domain is. (**B**) Recorded meristem shapes plotted as parabolas. The horizontal span of a plain parabola corresponds to the width of the treated image. (**C**) Modeled meristem and expression domain shapes. The *x* axis shows the different tissue templates displayed in fig. S12. For the parameter sets optimized for the 2D template, the *y* axis shows *WUS* expression domain elongation (longest vertical axis over longest horizontal axis). (**D**) Examples of processed images. The automatically defined parabolas and expression domains axes are plotted in blue. Scale bar, 20 μm.](1500989-F3){#F3}

Strikingly, the data also show a variability of the position of the *WUS* domain relative to the tip of the meristem: for the same genotype and similar growth conditions, the highest expression point of *WUS* may be either the third or the fourth cell layer (figs. S8 to S13). Although the model was optimized for a specific position and size of the expression domains, variability in positioning of WUS would easily be achieved by minor changes in the model parameter values or noise in the reaction rates.

A recurring morphological change in the SAM is the initiation of floral buds at its periphery. Following the tissue deformation marking the forming organ, new *WUS* and stem cell domains are established in domains resembling the SAM domains ([Fig. 4](#F4){ref-type="fig"}); the developmental program leading to a fully differentiated flower then proceeds. As of now, no mechanism explaining the formation of the flower *CLV3* and *WUS* domains has been identified. The model applied to a tissue template altered to comprise a dome-shaped SAM and a growing primordium-like lateral structure shows that the geometrical alteration is sufficient to generate new *WUS* and *CLV3* domains in the primordium, along with maintaining the domains in the SAM ([Fig. 4](#F4){ref-type="fig"}, movie S1, and Supplementary Materials). Hence, our model can discern between general size changes in the meristem, adapting the expression domains, and can account for more precise morphological changes, such as bud formation where it can promote the induction of new stem cell domains. Experimentally proving that the geometrical changes in the tissue upon flower formation cause the appearance of new stem cell domain is a difficult task. However, as the live image acquisition and processing steadily improve, it should be possible within the next few years to test this hypothesis using single cell resolution time courses, encompassing the meristematic tissue and the precise morphological changes associated with flower development (including the cryptic bract and multiple stages of flower development).

![A localized tissue deformation is sufficient to explain the formation of new stem cell domains in flower primordia.\
(**A**) Model equilibria in a set of different tissues mimicking the growth of a flower primordium. As the deformation expands, new *WUS* and *CLV3* domains appear in the expanding organ. (**B**) Top-view projections of *WUS* and *CLV3* expression domains in a SAM surrounded by flower primordia at different stages. Older (larger) primordia express the constructs whereas the younger ones do not. Scale bars, 50 μm.](1500989-F4){#F4}

To understand the source of the adaptability of the system, we explored the parameter values from multiple model optimizations. The analysis reveals that two types of epidermal signals are required to achieve the wild-type expression domains ([Fig. 5A](#F5){ref-type="fig"} and fig. S22). Indeed, in all cases, cytokinin is a long-range signal, with its diffusion rate much larger than its degradation rate. This observation is coherent with the small size of cytokinin and its involvement in organism-scale signaling ([@R26]). The three other signals produced in the L1 are short range and predicted to form similar gradients within the tissue.

![Scaling mechanism: Two types of epidermal signals form an incoherent feed-forward motif.\
(**A**) Ratios between diffusion and degradation rates for the L1 signals obtained after multiple optimizations of the 2D template (left). Dashed lines mark the shape of the resulting gradients (right). The bottom two examples represent gradients from short-range signals, whereas the top one represents a gradient from a long-range signal. (**B**) The incoherent feed-forward network motif activating *WUS*. (**C**) Illustration of the mechanism within a simplified model \[shown in (B)\] simulated on a 1D tissue of varying size (Supplementary Materials). Lines show signal concentrations (red, cytokinin; green, AHK-), and dashed lines are activity thresholds (*k*~cyt~, *k*~ahk~); the point where the concentration of a signal meets its threshold is represented by a large dot. *WUS* expression is shown in blue. *WUS* is activated to the right of the red dot and repressed to the right of the green dot. When the tissue size varies, the distance between the red and the green dots changes, causing the *WUS* expression domain to scale with the tissue (left). As the tissue expands, a de novo *WUS* expression domain is formed when the red dot passes the green dot (right). Note that the regulations are not step functions and some "leakage" of expression appears outside the activity thresholds.](1500989-F5){#F5}

The identified long-range and short-range epidermal signals are combined into an incoherent feed-forward regulation of WUS expression ([Fig. 5B](#F5){ref-type="fig"}). This motif by itself accounts for the positioning and scaling of the pattern ([Fig. 5C](#F5){ref-type="fig"}). The short-range AHK- signal remains largely unaffected by size changes, whereas the long-range cytokinin signal scales with tissue size. As the tissue expands, cytokinin meets its concentration threshold further away from the L1 and the AHK- threshold, leading to an increase of the *WUS* domain. The same effect can explain the appearance of *WUS* in primordia as they grow ([Fig. 5C](#F5){ref-type="fig"}) and the lateral expansion of the domains in flatter tissues by juxtaposing cell layers (cf. [Figs. 2A](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}).

We use a quantitative representation of some of the most studied expression domains and molecular interactions participating in the homeostasis of the SAM and show that this regulatory network is sufficient to describe domains in wild-type and perturbed plants. We propose the interactions between external cell layers and internal tissue as a mechanism to understand the stem cell regulation in the SAM. In particular, we propose that the combination of long- and short-range epidermal signals for the activation of *WUS* expression provides a mechanism for adaptive scaling and for the emergence of stem cell domains in flower primordia. This regulation of the gene expression domains by the geometry of the tissue offers a straightforward way of adapting the size of the stem cell domains to the host tissue, possibly allowing plants to fit their need for new cells to their environmental conditions and providing a mechanism allowing for the wide variety of SAM sizes in plant species to develop.

We have shown the ability of our model to describe a large amount of previously reported and novel behaviors of the system. However, the description relies on hypotheses, one of the major ones being the epidermis-based cytokinin gradient activating *WUS* expression. Because cytokinins have not been precisely measured in the SAM, we formulated the hypothesis on the basis of convergent clues, with attention to parsimony. First of all, cytokinins have been known for many years to be diffusive molecules ([@R26]) and have been shown to form a concentration gradient in the root meristem ([@R27]). Second, the connection between cytokinin and shoot development has been reported several times: multiple *LOG* mutant induces dwarf development in *Arabidopsis* ([@R28]), *LOG* mutant induces meristem termination in rice ([@R29]), and external application has been shown to increase *WUS* expression ([@R15], [@R30]). Third, we could only detect *LOG4* and *LOG7* in the SAM, both expressed along the epidermis. The L1 was thus used as the source of cytokinin in the model. A localized source of cytokinin is sufficient to create a cytokinin gradient, and this gradient in combination with the AHK- signal is sufficient to explain *WUS* expression domain position and shape in relation to tissue geometry. Given the current data, the cytokinin gradient control of *WUS* is the most parsimonious hypothesis we could formulate. Future work will need to also explore hypotheses involving additional factors. For instance, the cytokinin-degrading *CKXs* enzymes are expressed in the SAM and procambium and affect *WUS* expression and meristem size ([@R31]). *CKXs* are also induced by cytokinin signaling ([@R32]). Whether their role in the meristem is to reinforce the robustness of *WUS* expression to cytokinin fluctuations via this negative feedback or to have a defining role on *WUS* expression remains to be fully assessed.

The second major hypothesis of the model is the AHK- signal. The formulation of this hypothesis is based on the expression pattern of the *AHK* genes in the SAM ([Fig. 1](#F1){ref-type="fig"}). As pointed out, they are expressed away from the epidermis. Again, we formulated the hypothesis following Occam's razor and introduced a repressive signal keeping the AHKs away from the L1. This hypothesis is in line with the L1 originating signals used in previous efforts to model *CLV3* dynamics across various phenotypes \[notably the *pCLV3::WUS* phenotype ([@R22])\] and offers a straightforward explanation for the specific band-like expression domains observed in the large and flat *clv3* meristems ([Fig. 2A](#F2){ref-type="fig"}). The three predicted short-range signals form similar types of gradients, all falling sharply within a few cell layers of the L1, and thus following the L1 very closely. This suggests that the three overlapping signals could be mediated by similar means. miR394, produced in the L1 of the SAM and diffusing over a few cell layers, has been shown to participate in defining the stem cell domain ([@R18]). In line with this observation, microRNAs offer interesting molecular candidates to mediate the hypothesized short-range signals. The sharpness of the short-range signals resulting from the optimization also indicates that the model could accommodate "step-like" nondiffusing signals, as long as they follow the L1. For instance, lineage difference between tunica and corpus ([@R33]) would likely be sufficient as a positional cue. Another interesting candidate would be mechanical stresses as they have been suggested to be stronger in the epidermis and shown to regulate molecular behavior ([@R6], [@R34], [@R35]).

Although the *CLV3/WUS* feedback does provide robustness to the system (figs. S23 and S24), it does not enforce invariable expression domains and shows a remarkable adaptability to the shape of the meristematic tissue. The epidermis has a strong role in meristem growth and guiding mechanical properties ([@R6], [@R36]), therefore affecting tissue geometry. Our work fills the gap between geometry and gene expression via an epidermis-driven mechanism. The next major challenge is to understand how gene regulation interplays with mechanics and tissue geometry to balance the generation of new tissue and the control of the stem cell niche.

MATERIALS AND METHODS
=====================

The following describes the techniques used to compute the stable state of the models describing the gene expression patterns in the SAM. Two cases are presented:

1\) Abstract tissue. In the simplest scenario, the tissue is described with spherical cells. Molecules can diffuse between overlapping cells. No topological information other than cell neighborhood is taken into account.

2\) Realistic tissue. In the second scenario, the tissue geometry is drawn from segmented confocal images. In this case, computations make use of the realistic topology of the tissue, taking into account cell volumes and contact surfaces between cells.

Meristem topology
-----------------

In what is defined as the abstract tissue, the SAM is represented by a set of spheres corresponding to cells. Overlapping cells are considered in contact and can exchange diffusing molecules.

The complete abstract tissue is composed of cells enclosed in a 2D or a 3D parabola. The 3D tissue can be extended to account for a primordium; this is modeled by adding a half-sphere on the side of the parabola. The methods used to acquire the realistic template are described in the Realistic template section.

The abstract tissues count 369 and 2567 cells for the 2D and the 3D cases, respectively. The realistic tissue counts 3965 cells.

The expression domains of the genes of interest (*WUS*, *CLV3*, and *KAN1*) are defined on the template from experimental data (fig. S1). The epidermis (L1) is defined as the cells in contact with the parabola.A boundary acting as a sink is also defined as the cells at the bottom of the tissue; in those cells, diffusing molecules are eliminated from the system at a rate proportional to their diffusion. This boundary represents the forming vasculature and the connection to the rest of the plant.

Gene expression
---------------

RNA production is modeled using Hill functions; RNAs undergo a degradation *g*. For a set of *N*~*A*~ activators *A*~*a*~ and *N*~*I*~ inhibitors *I*~*b*~, the concentration of an RNA *X* varies as$$\frac{\mathit{d}\mathit{X}}{\mathit{d}\mathit{t}} = \mathit{V}\prod\limits_{\mathit{A}_{\mathit{a}}}^{\mathit{N}_{\mathit{A}}}\frac{\mathit{A}_{\mathit{a}}^{\mathit{n}_{\mathit{a}}}}{\mathit{A}_{\mathit{a}}^{\mathit{n}_{\mathit{a}}} + \mathit{k}_{\mathit{a}}^{\mathit{n}_{\mathit{a}}}}\prod\limits_{\mathit{I}_{\mathit{b}}}^{\mathit{N}_{\mathit{I}}}\frac{\mathit{k}_{\mathit{b}}^{\mathit{n}_{\mathit{b}}}}{\mathit{I}_{\mathit{b}}^{\mathit{n}_{\mathit{b}}} + \mathit{k}_{\mathit{b}}^{\mathit{n}_{\mathit{b}}}} - \mathit{g}\mathit{X}$$with *V* being the maximal rate of RNA production. The Hill constants *k* set the required concentration of activators or inhibitors to switch a gene between its active and inactive states. The Hill coefficients *n* control the slope of the transition between states. The equilibrium of *X* is found for$$\mathit{X} = \frac{\mathit{V}\prod_{\mathit{A}_{\mathit{a}}}^{\mathit{N}_{\mathit{A}}}\frac{\mathit{A}_{\mathit{a}}^{\mathit{n}_{\mathit{a}}}}{\mathit{A}_{\mathit{a}}^{\mathit{n}_{\mathit{a}}} + \mathit{k}_{\mathit{a}}^{\mathit{n}_{\mathit{a}}}}\prod_{\mathit{I}_{\mathit{b}}}^{\mathit{N}_{\mathit{I}}}\frac{\mathit{k}_{\mathit{b}}^{\mathit{n}_{\mathit{b}}}}{\mathit{I}_{\mathit{b}}^{\mathit{n}_{\mathit{b}}} + \mathit{k}_{\mathit{b}}^{\mathit{n}_{\mathit{b}}}}}{\mathit{g}}$$

Molecular transport
-------------------

Molecular movement between cells is modeled by a passive diffusion-like transport across cell membranes. Such diffusing molecules are produced by a gene expression domain (*WUS*, *CLV3*) or the L1. This domain is referred to as *P*, a vector of cell RNA concentrations for gene expression or a vector of 1 or 0 indicating that a cell belongs to the L1 or not. The domain is associated to a production rate *p*.

The bottom cell layer of the tissue represents the sink, *S*. As for the L1, it is a vector of 1 and 0. In those cells, diffusing molecules undergo degradation equal to their diffusion rate *D*, approximating a continued flux into the nonmodeled tissue below the meristem. Diffusing molecules also undergo a passive degradation of rate *g*.

For a vector of concentrations of a diffusing molecule *x*, we have$$\frac{\mathit{d}\mathit{x}}{\mathit{d}\mathit{t}} = \mathit{p}\mathit{P} - \mathit{g}\mathit{x} + \mathit{D}\Delta\mathit{x} - \mathit{D}\mathit{S}\mathit{x}$$where Δ is the Laplace operator; transport in the model is assumed to be passive.

For the abstract templates and a cell *i* with *n*~*i*~ neighbors *j*, the diffusion of *x* follows$$\frac{\mathit{d}\mathit{x}_{\mathit{i}}}{\mathit{d}\mathit{t}} = \mathit{D}\left( \sum\limits_{\mathit{j}}^{\mathit{n}_{\mathit{i}}}(\mathit{x}_{\mathit{j}} - \mathit{n}_{\mathit{i}}\mathit{x}_{\mathit{i}}) \right)$$

For the realistic template and a cell *i* of volume *V*~*i*~ and surface contact with its neighbors *C*~*i*~, having *n*~*i*~ neighbors *j* sharing a contact area *C*~*ij*~ with *i*

$$\frac{\mathit{d}\mathit{x}_{\mathit{i}}}{\mathit{d}\mathit{t}} = \frac{\mathit{D}}{\mathit{V}_{\mathit{i}}}\sum\limits_{\mathit{j}}^{\mathit{n}_{\mathit{j}}}\mathit{C}_{\mathit{i}\mathit{j}}(\mathit{x}_{\mathit{j}} - \mathit{x}_{\mathit{i}})$$

Finally, the equilibrium state of the considered molecule is found by solving$$\mathit{p}\mathit{P} - \mathit{g}\mathit{x} + \mathit{D}\Delta\mathit{x} - \mathit{D}\mathit{S}\mathit{x} = 0$$

Here, this is achieved using the linalg.solve function of the python scientific package SciPy ([www.scipy.org](http://www.scipy.org)).

Model
-----

The model is described by a set of nine differential equations for each cell. It comprises the dynamics of three gene RNAs: *WUS* (*W*), *CLV3* (*C*), and *KAN1* (*K*) and the modeled protein/peptides WUS (*w*) and CLV3 (*c*). It also describes the dynamics of four signals produced by the external cell layer: *L*~*c*~, *L*~*a*~, *L*~*C*~, and *L*~*K*~, which stand for cytokinin, AHK-, *CLV3* activator, and *KAN1* activator, respectively. The L1 cell layer and the sink are *L* and *S*, respectively.

$$\frac{\mathit{d}\lbrack\mathit{W}\rbrack}{\mathit{d}\mathit{t}} = \mathit{V}_{\mathit{W}} \times \frac{{\lbrack\mathit{L}_{\mathit{c}}\rbrack}^{\mathit{n}_{\mathit{L}_{\mathit{c}}\mathit{W}}}}{\mathit{k}_{\mathit{L}_{\mathit{c}}\mathit{W}}^{\mathit{n}_{\mathit{L}_{\mathit{c}}\mathit{W}}} + {\lbrack\mathit{L}_{\mathit{c}}\rbrack}^{\mathit{n}_{\mathit{L}_{\mathit{c}}\mathit{W}}}} \times \frac{\mathit{k}_{\mathit{L}_{\mathit{a}}\mathit{W}}^{\mathit{n}_{\mathit{L}_{\mathit{a}}\mathit{W}}}}{\mathit{k}_{\mathit{L}_{\mathit{a}}\mathit{W}}^{\mathit{n}_{\mathit{L}_{\mathit{a}}\mathit{W}}} + {\lbrack\mathit{L}_{\mathit{a}}\rbrack}^{\mathit{n}_{\mathit{L}_{\mathit{a}}\mathit{W}}}} \times \frac{\mathit{k}_{\mathit{c}\mathit{W}}^{\mathit{n}_{\mathit{c}\mathit{W}}}}{\mathit{k}_{\mathit{c}\mathit{W}}^{\mathit{n}_{\mathit{c}\mathit{W}}} + {\lbrack\mathit{c}\rbrack}^{\mathit{n}_{\mathit{c}\mathit{W}}}} - \mathit{g}_{\mathit{W}}\lbrack\mathit{W}\rbrack$$$$\frac{\mathit{d}\lbrack\mathit{w}\rbrack}{\mathit{d}\mathit{t}} = \mathit{p}_{\mathit{w}}\lbrack\mathit{W}\rbrack - \mathit{g}_{\mathit{w}}\lbrack\mathit{w}\rbrack + \mathit{D}_{\mathit{w}}\Delta\lbrack\mathit{w}\rbrack - \mathit{D}_{\mathit{w}}\mathit{S}\lbrack\mathit{w}\rbrack$$$$\frac{\mathit{d}\lbrack\mathit{C}\rbrack}{\mathit{d}\mathit{t}} = \mathit{V}_{\mathit{C}} \times \frac{{\lbrack\mathit{L}_{\mathit{C}}\rbrack}^{\mathit{n}_{\mathit{L}_{\mathit{C}}\mathit{C}}}}{\mathit{k}_{\mathit{L}_{\mathit{C}}\mathit{C}}^{\mathit{n}_{\mathit{L}_{\mathit{C}}\mathit{C}}} + {\lbrack\mathit{L}_{\mathit{C}}\rbrack}^{\mathit{n}_{\mathit{L}_{\mathit{C}}\mathit{C}}}} \times \frac{{\lbrack\mathit{w}\rbrack}^{\mathit{n}_{\mathit{w}\mathit{C}}}}{\mathit{k}_{\mathit{w}\mathit{C}}^{\mathit{n}_{\mathit{w}\mathit{C}}} + {\lbrack\mathit{w}\rbrack}^{\mathit{n}_{\mathit{w}\mathit{C}}}} - \mathit{g}_{\mathit{C}}\lbrack\mathit{C}\rbrack$$$$\frac{\mathit{d}\lbrack\mathit{c}\rbrack}{\mathit{d}\mathit{t}} = \mathit{p}_{\mathit{c}}\lbrack\mathit{C}\rbrack - \mathit{g}_{\mathit{c}}\lbrack\mathit{c}\rbrack + \mathit{D}_{\mathit{c}}\Delta\lbrack\mathit{c}\rbrack - \mathit{D}_{\mathit{c}}\mathit{S}\lbrack\mathit{c}\rbrack$$$$\frac{\mathit{d}\lbrack\mathit{K}\rbrack}{\mathit{d}\mathit{t}} = \mathit{V}_{\mathit{K}} \times \frac{{\lbrack\mathit{L}_{\mathit{K}}\rbrack}^{\mathit{n}_{\mathit{L}_{\mathit{K}}\mathit{K}}}}{\mathit{k}_{\mathit{L}_{\mathit{K}}\mathit{K}}^{\mathit{n}_{\mathit{L}_{\mathit{K}}\mathit{K}}} + {\lbrack\mathit{L}_{\mathit{K}}\rbrack}^{\mathit{n}_{\mathit{L}_{\mathit{K}}\mathit{K}}}} \times \frac{\mathit{k}_{\mathit{w}\mathit{K}}^{\mathit{n}_{\mathit{w}\mathit{K}}}}{\mathit{k}_{\mathit{w}\mathit{K}}^{\mathit{n}_{\mathit{w}\mathit{K}}} + {\lbrack\mathit{w}\rbrack}^{\mathit{n}_{\mathit{w}\mathit{K}}}} - \mathit{g}_{\mathit{K}}\lbrack\mathit{K}\rbrack$$$$\frac{\mathit{d}\mathit{L}_{\mathit{c}}}{\mathit{d}\mathit{t}} = \mathit{p}_{\mathit{L}_{\mathit{c}}}\mathit{L} - \mathit{g}_{\mathit{L}_{\mathit{c}}}\lbrack\mathit{L}_{\mathit{c}}\rbrack + \mathit{D}_{\mathit{L}_{\mathit{c}}}\Delta\lbrack\mathit{L}_{\mathit{c}}\rbrack - \mathit{D}_{\mathit{L}_{\mathit{c}}}\mathit{S}\lbrack\mathit{L}_{\mathit{c}}\rbrack$$$$\frac{\mathit{d}\mathit{L}_{\mathit{a}}}{\mathit{d}\mathit{t}} = \mathit{p}_{\mathit{L}_{\mathit{a}}}\mathit{L} - \mathit{g}_{\mathit{L}_{\mathit{a}}}\lbrack\mathit{L}_{\mathit{a}}\rbrack + \mathit{D}_{\mathit{L}_{\mathit{a}}}\Delta\lbrack\mathit{L}_{\mathit{a}}\rbrack - \mathit{D}_{\mathit{L}_{\mathit{a}}}\mathit{S}\lbrack\mathit{L}_{\mathit{a}}\rbrack$$$$\frac{\mathit{d}\mathit{L}_{\mathit{C}}}{\mathit{d}\mathit{t}} = \mathit{p}_{\mathit{L}_{\mathit{C}}}\mathit{L} - \mathit{g}_{\mathit{L}_{\mathit{C}}}\lbrack\mathit{L}_{\mathit{C}}\rbrack + \mathit{D}_{\mathit{L}_{\mathit{C}}}\Delta\lbrack\mathit{L}_{\mathit{C}}\rbrack - \mathit{D}_{\mathit{L}_{\mathit{C}}}\mathit{S}\lbrack\mathit{L}_{\mathit{C}}\rbrack$$$$\frac{\mathit{d}\mathit{L}_{\mathit{K}}}{\mathit{d}\mathit{t}} = \mathit{p}_{\mathit{L}_{\mathit{K}}}\mathit{L} - \mathit{g}_{\mathit{L}_{\mathit{K}}}\lbrack\mathit{L}_{\mathit{K}}\rbrack + \mathit{D}_{\mathit{L}_{\mathit{K}}}\Delta\lbrack\mathit{L}_{\mathit{K}}\rbrack - \mathit{D}_{\mathit{L}_{\mathit{K}}}\mathit{S}\lbrack\mathit{L}_{\mathit{K}}\rbrack$$

The full system is 3321, 23,103, and 35,685 equations in the 2D abstract, 3D abstract, and realistic tissues, respectively. Given that the exact signaling pathways controlling the gene expressions are not fully known, we simplified RNA production in the model to single Hill equations combining input factors from activators and repressors. *WUS* regulation is controlled by the incoherent feed-forward regulation from the L1 where the activating cytokinin (*L*~*c*~) is combined with the repressing AHK- (*L*~*a*~). We have abstracted the repression from the L1 of the cytokinin receptors (AHKs) and the receptors' part in activating *WUS* in the single AHK- signal. An additional factor represents *CLV3* repression (*c*). Following the same principle, we have combined activating L1 signals with WUS activation (repression) for regulation of *CLV3* (*KAN1*).

Parameter values
----------------

Because parameter values are unknown, they are inferred via an optimization strategy. To maintain the computations linear, we propose a workaround for the *CLV3*/*WUS* feedback loop by optimizing the system in several steps, where subparts of the network are optimized and the resulting optimized parameters are carried forward to the following steps until the full model is optimized. All optimizations are carried out using the CMA-ES algorithm ([@R21]).

The strategy can be summarized as follows: (step 1) optimize the *WUS* domain using the static *CLV3* domain (Ct) as defined in the template (fig. S1), (step 2) optimize the *CLV3* domain keeping the optimized *WUS* domain fixed, and (step 3) optimize the CLV3 gradient such that the optimized *CLV3* domain produces a gradient as similar as possible to the one resulting from the first step. This is followed by a confirmation step (step 4), where the equilibrium of the complete optimized network is computed. Finally, relevant *KAN1* expression domain is computed in step 5. For steps 1, 2, and 5, the optimization proceeds to the next step if parameters are found, for which the cost function falls below a defined threshold. The step is repeated otherwise. If step 4 fails to achieve equilibrium, the optimization restarts at step 1. A schematic of the optimization strategy is provided in fig. S2.

In the following, diff(*P*) will refer to computing the equilibrium concentration of a diffusing molecule across the tissue, given a production domain *P*. *P* is a cell vector containing either 1s (L1) or 0s (non-L1) if the production domain is the L1. *P* is a cell vector of RNA concentrations if it refers to the expression domains of *WUS* or *CLV3* (the equilibrium computation is described in the Molecular transport section). Similarly, $\text{eq}(\left\lbrack \mathit{A}_{1}\ldots\mathit{A}_{\mathit{N}_{\mathit{A}}} \right\rbrack,\left\lbrack \mathit{I}_{1}\ldots\mathit{I}_{\mathit{N}_{\mathit{I}}} \right\rbrack)$ will refer to computing the equilibrium of a gene expression regulated by *N*~*A*~ activators *A* and *N*~*I*~ inhibitors *I* (both activators and inhibitors are cell vectors of diffusing molecule concentrations; the equilibrium computation is described in the Gene expression section).

The function mes(*X*,*Y*,\[*p*,γ\]) measures the difference between two vectors *X* and *Y* following $\sum\limits_{\mathit{i}}{(\mathit{X}_{\mathit{i}} - \mathit{Y}_{\mathit{i}})}^{2}$ and is the main part of the cost functions used in the different steps of the optimization strategy. It allows one to differently weight some indices in the final sum, allowing, for instance, the computation of the difference only on subelements of the vectors or a different weight (*p*) to be attributed to cells for which the condition γ is met. This is used to increase the weight in the cost function for cells within the expression domains of target genes because these are fewer than cells outside the domains. For the 3D abstract template and the realistic template, this function is computed only on what is defined as the meristem (see fig. S1). As such, for these two templates, the expression domains present in the primordia are considered to be predictions of the model.

### Step 1: *WUS* expression domain

The optimization first minimizes the difference between *WUS* as defined in the template (*W*~*t*~) and *WUS* (*W*) at equilibrium \[where cells expressing *WUS* (*W*~*t*~ = 1) have an increased weight *p*~0~\]. A second component of the cost function ensures that the *WUS* domain (*W*~2~) is enlarged in *clavata* compared to wild-type (which is added as a sigmoidal contribution defined by *p*~2~, *p*~3~ with maximal weight *p*~1~). Finally, a third component limits the Hill coefficient values by weighting them with a factor *p*~4~, ensuring that the resulting expression domains are smoother than the binary domains defined in the template. The cost function, *E*~*W*~, is defined by$$\mathit{E}_{\mathit{W}} = \text{mes}(\mathit{W},\mathit{W}_{\mathit{t}},\lbrack\mathit{p}_{0},\mathit{W}_{\mathit{t}} = 1\rbrack) + \mathit{p}_{1}\frac{\mathit{p}_{2}^{\mathit{p}_{3}}}{\frac{\left. \sum\mathit{W}_{2} \right.}{\sum\mathit{W}}^{\mathit{p}_{3}} + \mathit{p}_{2}^{\mathit{p}_{3}}} + \mathit{p}_{4}(\mathit{n}_{\mathit{L}_{\mathit{c}}\mathit{W}} + \mathit{n}_{\mathit{L}_{\mathit{a}}\mathit{W}} + \mathit{n}_{\mathit{c}\mathit{W}})$$

The computation of *WUS* at equilibrium for the wild-type and the *clavata* phenotype follows$$\begin{matrix}
{\mathit{L}_{\mathit{c}} = ~\text{diff}(\mathit{L})} \\
{\mathit{L}_{\mathit{a}} = ~\text{diff}(\mathit{L})} \\
{\mathit{c}_{\mathit{h}} = ~\text{diff}(\mathit{C}_{\mathit{t}})} \\
\begin{matrix}
{\mathit{W} = ~\text{eq}(\lbrack\mathit{L}_{\mathit{c}}\rbrack,\lbrack\mathit{L}_{\mathit{a}},\mathit{c}_{\mathit{h}}\rbrack)} \\
{\mathit{W}_{2} = ~\text{eq}(\lbrack\mathit{L}_{\mathit{c}}\rbrack,\lbrack\mathit{L}_{\mathit{a}}\rbrack)} \\
\end{matrix} \\
\end{matrix}$$

The parameters of [Eqs. 1](#E1){ref-type="disp-formula"}, [4](#E4){ref-type="disp-formula"}, [6](#E6){ref-type="disp-formula"}, and [7](#E7){ref-type="disp-formula"} are optimized.

### Step 2: *CLV3* expression domain

Following the same formalism as in the previous step, the second optimization minimizes the difference between *CLV3* as defined in the template (*C*~*t*~) and *CLV3* at equilibrium (*C*). A second component ensures that the Hill coefficient values are limited. The cost function, *E*~*C*~, is defined by$$\mathit{E}_{\mathit{C}} = ~\text{mes}(\mathit{C},\mathit{C}_{\mathit{t}},\lbrack\mathit{p}_{0},\mathit{C}_{\mathit{t}} = 1\rbrack) + \mathit{p}_{2}(\mathit{n}_{\mathit{L}_{\mathit{C}}\mathit{C}} + \mathit{n}_{\mathit{w}\mathit{C}})$$*CLV3* at equilibrium is computed following$$\begin{matrix}
{\mathit{L}_{\mathit{C}} = ~\text{diff}(\mathit{L})} \\
{\mathit{w} = ~\text{diff}(\mathit{W})} \\
{\mathit{C} = ~\text{eq}(\lbrack\mathit{L}_{\mathit{C}},\mathit{w}\rbrack,\lbrack\rbrack)} \\
\end{matrix}$$

The parameters of [Eqs. 2](#E2){ref-type="disp-formula"}, [3](#E3){ref-type="disp-formula"}, and [8](#E8){ref-type="disp-formula"} are optimized.

### Step 3: *CLV3* peptide gradient

The first step of the optimization used a hypothetical CLV3 signal (*c*~*h*~) produced by the manually defined *CLV3* expression domain. As an equilibrium *CLV3* domain has been computed, one can compute the corresponding equilibrium for the CLV3 peptide. Optimizing CLV3 aims at minimizing its difference from the previously computed *c*~*h*~.

Equilibrium for CLV3 follows$$\mathit{c} = ~\text{diff}(\mathit{C})$$and the cost function is$$\mathit{E}_{\mathit{c}} = ~\text{mes}(\mathit{c},\mathit{c}_{\mathit{h}},\lbrack\rbrack)$$

The parameters of [Eq. 4](#E4){ref-type="disp-formula"} are reoptimized (the parameters of [Eq. 4](#E4){ref-type="disp-formula"} optimized in step 1 are discarded).

### Step 4: *CLV3*/*WUS* feedback loop: Equilibrium of the core model

As the previous steps of the optimization independently found equilibria for components of the model, one has to ensure that an adequate stable equilibrium state exists for the complete model as well. The feedback between *WUS* and *CLV3* tends to induce dampened oscillations of the two genes. We propose an algorithm making use of that aspect and designed to quickly reach the equilibrium of the system using the parameter values obtained in the previous steps$$\mathit{E}_{\mathit{d}} = \left. \sum{}^{\mathit{i}} \right.\left( \frac{\mathit{d}\mathit{w}_{\mathit{i}}}{\mathit{d}\mathit{t}}^{2} + \frac{\mathit{d}\mathit{c}_{\mathit{i}}}{\mathit{d}\mathit{t}}^{2} \right)$$whereas *E*~*d*~ \> *T*~0~$$\text{if}~\left. \sum{}^{\mathit{i}} \right.\frac{\mathit{d}\mathit{c}_{\mathit{i}}}{\mathit{d}\mathit{t}}^{2} < \left. \sum{}^{\mathit{i}} \right.\frac{\mathit{d}\mathit{w}_{\mathit{i}}}{\mathit{d}\mathit{t}}^{2}$$$$\mathit{W} = ~\text{eq}(\lbrack\mathit{L}_{\mathit{c}}\rbrack,\lbrack\mathit{L}_{\mathit{a}},\mathit{c}\rbrack)$$$$\mathit{w} = \frac{\text{diff}(\mathit{W}) + \mathit{w}}{2}$$$$\mathit{C} = ~\text{eq}(\lbrack\mathit{L}_{\mathit{C}},\mathit{w}\rbrack,\lbrack{}\rbrack)$$$$\mathit{c} = \frac{\text{diff}(\mathit{C}) + \mathit{c}}{2}$$else$$\mathit{C} = ~\text{eq}(\lbrack\mathit{L}_{\mathit{C}},\mathit{w}\rbrack,\lbrack\rbrack)$$$$\mathit{c} = \frac{\text{diff}(\mathit{C}) + \mathit{c}}{2}$$$$\mathit{W} = ~\text{eq}(\lbrack\mathit{L}_{\mathit{c}}\rbrack,\lbrack\mathit{L}_{\mathit{a}},\mathit{c}\rbrack)$$$$\mathit{w} = \frac{\text{diff}\left( \mathit{W}) + \mathit{w} \right.}{2}$$$$\mathit{E}_{\mathit{d}} = \left. \sum{}^{\mathit{i}} \right.\left( \frac{\mathit{d}\mathit{w}_{\mathit{i}}}{\mathit{d}\mathit{t}}^{2} + \frac{\mathit{d}\mathit{c}_{\mathit{i}}}{\mathit{d}\mathit{t}}^{2} \right)$$

At this point in the optimization, the eigenvalues of the system are computed to verify whether the equilibrium is an attractor. If they are all negative, the optimization proceeds. We also used numerical ordinary differential equation integrations to confirm equilibria for specific parameter values.

### Step 5: KAN1 expression domain

The equilibrium of *KAN1* can be computed after the equilibrium of the core model is obtained. This part of the optimization minimizes the difference between *KAN1* at equilibrium and the manually defined *KAN1* domain (*K*~*t*~). The cost function also contains a component limiting the value of the Hill coefficients involved. For the abstract 3D template, the mes element of the cost function is only evaluated in the half of the template that does not contain the primordium.

The equilibrium for *KAN1* is obtained via$$\begin{matrix}
{\mathit{L}_{\mathit{K}} = ~\text{diff}(\mathit{L})} \\
{\mathit{K} = ~\text{eq}(\lbrack\mathit{L}_{\mathit{K}}\rbrack,\lbrack\mathit{w}\rbrack)} \\
\end{matrix}$$and the cost function is$$\mathit{E}_{\mathit{K}} = ~\text{mes}(\mathit{K},\mathit{K}_{\mathit{t}},\lbrack\mathit{p}_{0},\mathit{K}_{\mathit{t}} = 1\rbrack) + \mathit{p}_{2}(\mathit{n}_{\mathit{L}_{\mathit{K}}\mathit{K}} + \mathit{n}_{\mathit{w}\mathit{K}})$$

The parameters of [Eqs. 5](#E5){ref-type="disp-formula"} and [9](#E9){ref-type="disp-formula"} are optimized.

### Optimization results

For the 2D abstract, the 3D abstract, and the realistic tissue templates, the optimizations resulted in 255, 40, and 6 parameter sets, respectively, correctly describing the wild-type gene expression patterns and exhibiting an increase of *WUS* expression for the *clavata* phenotype. Example parameter sets are given in table S1.

Computing equilibrium for wild type, mutants, and sensitivity analysis
----------------------------------------------------------------------

Using the conventions defined in the previous section, the equilibrium of the L1 model can be found using optimized parameters. The wild-type cases use the parameters obtained from optimization and the tissue templates.

Using the parameters of the equations for L1 signals (cytokinin, AHK-, and *CLV3*, respectively)$$\begin{matrix}
{\mathit{L}_{\mathit{c}} = ~\text{diff}(\mathit{L})} \\
{\mathit{L}_{\mathit{a}} = ~\text{diff}(\mathit{L})} \\
{\mathit{L}_{\mathit{C}} = ~\text{diff}(\mathit{L})} \\
\end{matrix}$$

On the basis of those signals, *WUS* and WUS are computed, followed by *CLV3* and CLV3. They correspond to a *clv3* loss of function scenario$$\begin{matrix}
{\mathit{W} = ~\text{eq}(\lbrack\mathit{L}_{\mathit{c}}\rbrack,\lbrack\mathit{L}_{\mathit{a}}\rbrack)} \\
{\mathit{w} = ~\text{diff}(\mathit{W})} \\
{\mathit{C} = ~\text{eq}(\lbrack\mathit{L}_{\mathit{C}},\mathit{w}\rbrack,\lbrack\rbrack)} \\
{\mathit{c} = ~\text{diff}(\mathit{C})} \\
\end{matrix}$$

The *CLV3*/*WUS* feedback loop algorithm from the optimization section is then applied to obtain the stable states *WUS*, WUS, *CLV3*, and CLV3.

Finally, for the abstract templates, *KAN1* is computed$$\begin{matrix}
{\mathit{L}_{\mathit{K}} = ~\text{diff}(\mathit{L})} \\
{\mathit{K} = ~\text{eq}(\lbrack\mathit{L}_{\mathit{K}}\rbrack,\lbrack\mathit{w}\rbrack)} \\
\end{matrix}$$

The mutants presented in fig. S3 are computed by changing either the parameter values or the equations$$\left. \mathit{w}\mathit{u}\mathit{s}~\text{loss\ of\ function}~:\mathit{p}_{\mathit{w}}\rightarrow 0 \right.$$$$\left. \mathit{c}\mathit{l}\mathit{v}3~\text{loss\ of\ function}~:\mathit{p}_{\mathit{c}}\rightarrow 0(\text{also\ computed\ along\ with}\mathit{w}\mathit{i}\mathit{l}\mathit{d}\mathit{t}\mathit{y}\mathit{p}\mathit{e}) \right.$$$$\left. \mathit{p}35\mathit{S}::\mathit{W}\mathit{U}\mathit{S}:\frac{\mathit{d}\lbrack\mathit{w}\rbrack}{\mathit{d}\mathit{t}}\rightarrow\mathit{p}_{\mathit{w}}(\lbrack\mathit{W}\rbrack + \mathit{V}_{\mathit{W}}) - \mathit{g}_{\mathit{w}}\lbrack\mathit{w}\rbrack + \mathit{D}_{\mathit{w}}\Delta\lbrack\mathit{w}\rbrack - \mathit{D}_{\mathit{w}}\mathit{S}\lbrack\mathit{w}\rbrack \right.$$$$\left. \mathit{p}35\mathit{S}::\mathit{C}\mathit{L}\mathit{V}3:\frac{\mathit{d}\lbrack\mathit{c}\rbrack}{\mathit{d}\mathit{t}}\rightarrow\mathit{p}_{\mathit{c}}(\lbrack\mathit{C}\rbrack + \mathit{V}_{\mathit{C}}) - \mathit{g}_{\mathit{c}}\lbrack\mathit{c}\rbrack + \mathit{D}_{\mathit{c}}\Delta\lbrack\mathit{c}\rbrack - \mathit{D}_{\mathit{c}}\mathit{S}\lbrack\mathit{c}\rbrack \right.$$$$\left. \mathit{p}\mathit{C}\mathit{L}\mathit{V}3::\mathit{W}\mathit{U}\mathit{S}:\frac{\mathit{d}\lbrack\mathit{W}\rbrack}{\mathit{d}\mathit{t}}\rightarrow\mathit{V}_{\mathit{W}} \times \frac{{\lbrack\mathit{L}_{\mathit{c}}\rbrack}^{\mathit{n}_{\mathit{L}_{\mathit{c}}\mathit{W}}}}{\mathit{k}_{\mathit{L}_{\mathit{c}}\mathit{W}}^{\mathit{n}_{\mathit{L}_{\mathit{c}}\mathit{W}}} + {\lbrack\mathit{L}_{\mathit{c}}\rbrack}^{\mathit{n}_{\mathit{L}_{\mathit{c}}\mathit{W}}}} \times \frac{\mathit{k}_{\mathit{L}_{\mathit{a}}\mathit{W}}^{\mathit{n}_{\mathit{L}_{\mathit{a}}\mathit{W}}}}{\mathit{k}_{\mathit{L}_{\mathit{a}}\mathit{W}}^{\mathit{n}_{\mathit{L}_{\mathit{a}}\mathit{W}}} + {\lbrack\mathit{L}_{\mathit{a}}\rbrack}^{\mathit{n}_{\mathit{L}_{\mathit{a}}\mathit{W}}}} \times \frac{\mathit{k}_{\mathit{c}\mathit{W}}^{\mathit{n}_{\mathit{c}\mathit{W}}}}{\mathit{k}_{\mathit{c}\mathit{W}}^{\mathit{n}_{\mathit{c}\mathit{W}}} + {\lbrack\mathit{c}\rbrack}^{\mathit{n}_{\mathit{c}\mathit{W}}}} - \mathit{g}_{\mathit{W}}\lbrack\mathit{W}\rbrack + \frac{\mathit{d}\lbrack\mathit{C}\rbrack}{\mathit{d}\mathit{t}} \right.$$$$\left. \mathit{p}\mathit{W}\mathit{U}\mathit{S}::\mathit{C}\mathit{L}\mathit{V}3:\frac{\mathit{d}\lbrack\mathit{C}\rbrack}{\mathit{d}\mathit{t}}\rightarrow\mathit{V}_{\mathit{C}} \times \frac{{\lbrack\mathit{L}_{\mathit{C}}\rbrack}^{\mathit{n}_{\mathit{L}_{\mathit{C}}\mathit{C}}}}{\mathit{k}_{\mathit{L}_{\mathit{C}}\mathit{C}}^{\mathit{n}_{\mathit{L}_{\mathit{C}}\mathit{C}}} + {\lbrack\mathit{L}_{\mathit{C}}\rbrack}^{\mathit{n}_{\mathit{L}_{\mathit{C}}\mathit{C}}}} \times \frac{{\lbrack\mathit{w}\rbrack}^{\mathit{n}_{\mathit{w}\mathit{C}}}}{\mathit{k}_{\mathit{w}\mathit{C}}^{\mathit{n}_{\mathit{w}\mathit{C}}} + {\lbrack\mathit{w}\rbrack}^{\mathit{n}_{\mathit{w}\mathit{C}}}} - \mathit{g}_{\mathit{C}}\lbrack\mathit{C}\rbrack + \frac{\mathit{d}\lbrack\mathit{W}\rbrack}{\mathit{d}\mathit{t}} \right.$$$$\left. \mathit{W}\mathit{U}\mathit{S}~\text{diffusion}~:\mathit{D}_{\mathit{w}}\rightarrow 0 \right.$$$$\left. \mathit{C}\mathit{L}\mathit{V}3~\text{diffusion}~:\mathit{D}_{\mathit{c}}\rightarrow 0 \right.$$$$\left. \text{Sink\ reduction}~:\mathit{S}\rightarrow\mathit{S} \times 0.5 \right.$$$$\left. \mathit{L}\mathit{O}\mathit{G}\mathit{s}~\text{loss\ of\ function}~:\mathit{p}_{\mathit{L}_{\mathit{C}}}\rightarrow 0 \right.$$$$\left. \mathit{p}\mathit{L}\mathit{O}\mathit{G}::\mathit{L}\mathit{O}\mathit{G}:\mathit{p}_{\mathit{L}_{\mathit{C}}}\rightarrow\mathit{p}_{\mathit{L}_{\mathit{C}}} \times 2 \right.$$$$\left. \mathit{A}\mathit{H}\mathit{K}\mathit{s}~\text{loss\ of\ function}~:\mathit{L}_{\mathit{a}}\rightarrow\text{max}(\text{diff}(\mathit{L})),\text{diff\ computed\ with}~\mathit{L}_{\mathit{a}}~\text{optimized\ parameters} \right.$$$$\left. \mathit{p}35\mathit{S}::\mathit{A}\mathit{H}\mathit{K}\mathit{s}:\mathit{L}_{\mathit{a}}\rightarrow 0 \right.$$

The same procedure is used to compute the sensitivity analysis presented in the figures. Each parameter of each parameter set optimized for the 2D abstract tissue is increased by 1%; the corresponding stable states for *CLV3* and *WUS* are computed and compared to their wild-type counterpart. The *y* axis of both figures displays $\frac{\Delta\mathit{m}}{\Delta\mathit{p}} \times \frac{\mathit{p}}{\mathit{m}}$, where *p* is the parameter value, Δ*p* is the modification applied, *m* is the measure (either *C* or *W* summed over all cells), and Δ*m* is the modification of the measure. Following this convention, the closer a result is to 0, the less sensitive a model is to variations of the considered parameter ([@R37]). Results are presented in figs. S23 and S24; the difference between the values obtained for the full model and the *clavata* phenotype shows the effect of the *CLV3*/*WUS* feedback loop in improving the robustness of the model.

Live imaging ([Fig. 1A](#F1){ref-type="fig"})
---------------------------------------------

### Reporter cloning

*pLOG4::2xYPET-N7* and *pLOG7::2xYPET-N7* were previously described by Chickarmane *et al*. ([@R16]). *pAHK2*, *pAHK3*, and *pAHK4* transcriptional reporter transgenes were constructed using standard molecular biology techniques. A tandem fusion of the *YPET* cDNA sequence with an *N7* nuclear localization signal sequence (2xYPET-N7) was inserted between the translation start site and the stop codon of each *AHK* gene by gateway-mediated recombination. *pAHK2::2xYPET-N7* and *pAHK3::2xYPET-N7* sequences were subcloned into the pMOA34 vector. The *pAHK4::2xYPET-N7* sequence was subcloned into the pMOA33 vector. Transgenic lines were established using the floral dip method. T1 plants were selected on the basis of the appropriate selection, hygromycin for *pAHK2::2xYPET-N7* and *pAHK3::2xYPET-N7* or kanamycin for *pAHK4::2xYPET-N7*. Subsequent resistant T1 individuals were further screened for the presence of signal in both the root tissue and the SAM tissue.

### Growth and imaging conditions

T3 generation homozygous plants were grown under continuous light in a growth chamber on soil at 19°C. Inflorescence SAMs were dissected from plants at a shoot height of approximately 1 cm. Floral primordia were removed, and the SAM was imaged underwater. All images were obtained on a Zeiss 780 upright confocal laser-scanning microscope. For each transgene reporter, conditions were standardized using a 40× 1.0 numerical aperture water-dipping lens. Samples were imaged using the 514-nm laser with the output attenuated to 5%. The digital gain was set between 720 and 800 depending on the transcriptional reporter transgene. For the *pAHK2* reporter, the laser output was attenuated to 10% total output to generate an image comparable to the other *pAHK* reporter transgenes. The digital offset was adjusted for each image such that all background pixels were not underexposed.

### Image processing

Each of the images was processed using ImageJ for background subtraction and adjustment of the brightness and contrast. These adjustments did not alter the interpretation of the original image data for the extraction of expression domains in the parameterization of the model.

Realistic template ([Fig. 1D](#F1){ref-type="fig"})
---------------------------------------------------

Wild-type *Arabidopsis* Columbia (Col.0) plants were grown on soil under short-day conditions (8 hours light) for a period of 3 weeks and were then subjected under long-day conditions (16 hours light) and allowed to bolt. After reaching a size of approximately 5 cm, the shoot apices were dissected under a stereo microscope. After carefully removing older flowers and floral primordia, the apices were stained with FM4-64 and imaged with a Zeiss LSM 780 confocal microscope. Confocal Z sections of the apical meristem with 0.5-μm depth were acquired at a neutral angle and two additional stacks of the same apical meristem were captured after tilting the sample in two different orientations of 20° to 30°. The three individual Z stacks were then fused to create a single sample. The merged 3D image is segmented. We used MARS ([@R20]) for the fusion and the segmentation. The segmented image can then be viewed as a 3D image in which the voxels (volumetric pixels) belonging to a given cell are marked by the same label. The labels can be considered as cell identifiers. From the segmented image, quantitative data on cell volumes, cell centers, and contact surfaces between neighboring cells were obtained. Apart from this, an adjacency graph in which vertices correspond to cells was also generated. The edges of the adjacency graph correspond to cell walls and connect cells to their neighbors. The output of the model was visualized using a 3D viewer implemented using VTK, python, NumPy, and SciPy packages.

In situ hybridization ([Fig. 2](#F2){ref-type="fig"})
-----------------------------------------------------

### Plant material and treatments

Col.0 plants were grown at 23°C under constant light condition. The dominant negative *clv1* allele corresponds to *clv1-8*, which was originally named *fully fasciated* ([@R38]).

### In situ hybridization

In situ hybridizations were performed in accordance with standard protocols ([@R39]). Polyvinyl alcohol was added to the nitro blue tetrazolium--bromochloroindolyl phosphate staining solution at a final concentration of 3%. RNA probes were in vitro transcribed from full-length coding regions.

Meristem size variations ([Fig. 2](#F2){ref-type="fig"})
--------------------------------------------------------

### Plant lines and growth conditions

Seeds of *A. thaliana*, ecotypes Col.0 and Wassilewskija (WS), were provided by the Arabidopsis Biological Resource Center (Ohio State University, Columbus, OH). *Clasp-1* was provided by G. Wasteneys and has been described previously ([@R40]). The ethanol-inducible transcriptional reporters for *WUS* and *CLAVATA3* were provided by P. Laufs and have also been described ([@R41], [@R42]). Plants were grown on soil in a phytotron under constant light or, if stated otherwise, under long-day conditions directly (16 hours/8 hours light/dark period) or under short-day conditions (8 hours/16 hours light/dark period) for 1 month and then under long-day conditions.

### Observation of SAMs

To access the inflorescence meristem, flowers and older floral buds \[up to stage 3 as defined by Smyth *et al*. ([@R43])\] were dissected out. Then, the meristem was cut and kept in an apex culture medium for imaging ([@R20]). To induce the expression of green fluorescent protein (GFP) in the *pWUS* \>\> *GFP* and *pCLV3* \>\> *GFP* lines, plants were kept in a box overnight in a wet atmosphere with ethanol vapors before they were dissected. The meristems were imaged using either a Zeiss LSM 700 or an LSM 780 upright confocal microscope: optical sections were obtained every 1 μm, and full projections of the stack of images and orthogonal sections were realized using the ImageJ software.

### Meristem quantifications

The measurements of meristem size were performed as described by Landrein *et al*. ([@R44]). To measure the size of the *WUS* and *CLV3* expression domains, 3D maximum intensity *z* projections of the confocal stacks were used, ensuring that the meristem was always oriented perpendicular to the *z* axis. Then, an ellipse was drawn manually around the projected domain and the surface of this ellipse was quantified using the ImageJ software. Note that as the *pWUS* \>\> *GFP* and *pCLV3* \>\> *GFP* lines were generated in a WS-4 background, the measurements of meristem size and expression domains in *clasp-1* and Col.0 were performed on an F2 segregation of the inter-ecotype crosses explaining the larger variation of meristem size observed in these genotypes \[see Landrein *et al*. ([@R44])\].

For simulated data on the templates of different sizes, the domain sizes are counts of cells having the expression of either *WUS* or *CLV3* above a threshold. For [Fig. 2](#F2){ref-type="fig"}, the threshold is set to 0.5.

### Regression analysis

The regressions were performed using the stats.linregress function of the SciPy scientific package for python. The given values are the slope and intercept of the regression line. A two-tailed *P* value testing the slope of the regression line being null as a null hypothesis is also given. Data from individual conditions are presented in figs. S5 and S6.

Meristem and expression domain geometrical quantifications ([Fig. 3](#F3){ref-type="fig"})
------------------------------------------------------------------------------------------

Not only do SAMs show size variations, the shape of the dome they form also varies. We measured that aspect on the pool of meristems used for the size analysis of [Fig. 2](#F2){ref-type="fig"}.

The first part of the image processing was done with the Fiji software ([@R45]). For each meristem confocal stack (composite colors), 5-μm-thick transversal sections cutting through the center of the meristem were extracted and further projected following maximum intensity. When necessary, images were rotated so that the meristem would be displayed vertically. The images were then cropped to contain only the SAMs. Finally, each image was converted to png format and analyzed using the python PIL library ([www.pythonware.com/products/pil/](http://www.pythonware.com/products/pil/)).

In the following, we consider a reference frame with an origin at the bottom left corner of each image where discrete *x* and *y* values correspond to pixel positions in the image. To measure the shape of a meristem, for each row of pixels, we extracted the topmost pixel registering FM4-64 fluorescence (for each *x*: maximum *y* with red channel value \>50). This results in a collection of *x*,*y* coordinates outlying the shape of the meristem. The parameters of a second-degree polynomial (describing a parabola) were then fit to the extracted coordinates using the numpy.polyfit function. The parameter *a* of a parabola described by *ax*^2^ + *bx* + *c* = 0 controls how narrow the domain contained within the parabola is (where *ax*^2^ + *bx* + *c* \< 0). In the case of the parabolas outlying the meristem shape, the higher the value of the *a* parameter, the flatter the meristem. This value was computed for each meristem. The parabolas and *a* parameters are displayed on the meristem images in figs. S8 to S19.

The same images were used to quantify the shape of the expression domains of the *pWUS* \>\> *GFP* and *pCLV3* \>\> *GFP* constructs. We chose to measure the elongation of the domains along the axis of the reference frame. To do so, we find the maximal distance between two pixels registering GFP fluorescence (green channel value \>50) and having the same *y* coordinate, giving us the longest horizontal axis of the GFP expression domain. We repeat the procedure using the same *x* coordinate and find the longest vertical axis. As a measure of the GFP domain elongation, we use the ratio of the longest vertical axis over the longest horizontal axis. Thus, the higher the value, the more the domain is horizontally elongated. Axis and elongation values are displayed on their corresponding meristem images in figs. S8 to S19.

[Figure 3A](#F3){ref-type="fig"} and fig. S7A show a correlation between the shape of the meristematic tissue and the shape of the expression domains of both *WUS* and *CLV3*. The flatter the SAM, the more horizontally elongated the domains of expression are. Figure S21 shows the correlation between the size of the meristems from [Fig. 2](#F2){ref-type="fig"} and the shape of the meristems. We observe a strong correlation between the shape of the tissue and its size, with the larger meristems also being the flatter ones. Note that the number of meristems plotted in fig. S21 may differ from the number of meristems displayed in figs. S8 to S19, because only the meristems that could also be processed for [Fig. 2](#F2){ref-type="fig"} are displayed. Regression analysis is performed as described in the previous section.

To assess if the L1 model can capture this effect, we generated a set of new 2D templates. The optimization template was first scaled by a factor and then scaled horizontally again by the same factor. This generated a set of smaller and narrower tissue templates and a set of larger and flatter ones. The factors displayed in fig. S20 are 0.9, 0.95, 1, 1.05, 1.1, 1.15, and 1.2. As exemplified, the larger and flatter meristems show elongated domains of expression for both *WUS* and *CLV3*, whereas the domains tend to narrow down for the smaller and narrower meristems. The data obtained for all parameter sets optimized for the 2D template are shown in [Fig. 3C](#F3){ref-type="fig"} and fig. S7C.

Primordium growth ([Fig. 4](#F4){ref-type="fig"} and movie S1)
--------------------------------------------------------------

Cells are allowed to grow by increasing the cell radii and are allowed to divide into two daughter cells when a threshold size is attained. A set of spring forces between cell centers moves cells apart when overlapping and back inside the lid when pushed out of it. Cells falling below the lower boundary of the lid are removed from the simulation ([@R12]).

As the simulation runs, a sphere moves from the inside of the parabola, exiting laterally, and stopping when its center reaches the parabola. As the sphere moves, the lid is updated to comprise the parabola and the part of the sphere outside of the parabola. This results in an increase of the space allocated to cells. The growth simulation is performed using the organism software (<http://dev.thep.lu.se/organism>).

For 200 time points evenly spaced over the length of the simulation, the cell positions and radii are recorded and the cells belonging to the boundaries (L1 and Sink) are found, allowing us to find the equilibrium of the L1 model as previously described. The final movie is obtained by assembling the equilibrium variables of the model for each time point.

It is worth noting that the growth and cell division algorithm used to generate the movie is noisy, likely more than what could be expected from the actual meristematic tissue. This generates large unrealistic fluctuations of the expression domains of *WUS* and *CLV3* as the simulation runs. Keeping such an algorithm, the fluctuations could however be reduced by extending the model to add additional feedback loops known to be present in the system, such as the negative feedback of cytokinin of its signaling mediated by type B *Arabidopsis* response regulators. Another plausible approach is to trade some of the expression domain pattern quality for more robustness of the patterns by adding additional components to the cost functions used in the optimization of the parameters.

*WUS* and *CLV3* live imaging ([Fig. 4](#F4){ref-type="fig"})
-------------------------------------------------------------

*pWUS::GFP-ER* and *pCLV3::dsRED-N7* plants were grown under conditions described in the Realistic template section. For the live imaging, plants were transferred immediately after bolting to square boxes containing lukewarm MS media with 1% agar and allowed to solidify. The plants were then stained with FM4-64 and imaged with a Zeiss LSM 780 confocal microscope.

1D simulations ([Fig. 5](#F5){ref-type="fig"})
----------------------------------------------

To illustrate the scaling effect driven by the incoherent feed-forward loop controlling *WUS* expression, simulations were performed on a set of 1D tissue templates (ranging from 5 to 14 cells), each having an L1 cell at one extremity and a Sink cell at the other. The simplified model comprises the activation of *WUS* mediated by cytokinin and its repression mediated by AHK4-.

The 10-cell template was chosen to manually fit the parameters of the system to obtain a central *WUS* domain. The chosen parameters are$$\begin{matrix}
{\mathit{V}_{\mathit{W}} = 1.7} \\
{\mathit{k}_{\mathit{L}_{\mathit{c}}\mathit{W}} = 0.75} \\
{\mathit{n}_{\mathit{L}_{\mathit{c}}\mathit{W}} = 10} \\
\begin{matrix}
{\mathit{k}_{\mathit{L}_{\mathit{a}}\mathit{W}} = 0.2} \\
{\mathit{n}_{\mathit{L}_{\mathit{a}}\mathit{W}} = 10} \\
{\mathit{g}_{\mathit{W}} = 1.7} \\
\begin{matrix}
{\mathit{p}_{\mathit{L}\mathit{c}} = 15} \\
{\mathit{g}_{\mathit{L}\mathit{c}} = 1} \\
{\mathit{D}_{\mathit{L}\mathit{c}} = 100} \\
\begin{matrix}
{\mathit{p}_{\mathit{L}\mathit{a}} = 2} \\
\begin{matrix}
{\mathit{g}_{\mathit{L}\mathit{a}} = 1} \\
{\mathit{D}_{\mathit{L}\mathit{a}} = 1} \\
\end{matrix} \\
\end{matrix} \\
\end{matrix} \\
\end{matrix} \\
\end{matrix}$$
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Fig. S1. Templates.

Fig. S2. Optimization strategy.

Fig. S3. The model is able to represent a large collection of perturbations.

Fig. S4. *pCLV3::WUS*.

Fig. S5. *WUS* domain size variation.

Fig. S6. *CLV3* domain size variation.

Fig. S7. *pCLV3* \>\> *GFP* meristem shapes and expression domains.

Fig. S8. clasp1 *pWUS* \>\> *GFP* meristems, grown in long days.

Fig. S9. clasp1 *pWUS* \>\> *GFP* meristems, grown in long days followed by short days.

Fig. S10. Col.0 *pWUS* \>\> *GFP* meristems, grown in long days.

Fig. S11. Col.0 *pWUS* \>\> *GFP* meristems, grown in long days followed by short days.

Fig. S12. WS-4 *pWUS* \>\> *GFP* meristems, grown in long days.

Fig. S13. WS-4 *pWUS* \>\> *GFP* meristems, grown in long days followed by short days.

Fig. S14. clasp1 *pCLV3* \>\> *GFP* meristems, grown in long days.

Fig. S15. clasp1 *pCLV3* \>\> *GFP* meristems, grown in long days followed by short days.

Fig. S16. Col.0 *pCLV3* \>\> *GFP* meristems, grown in long days.

Fig. S17. Col.0 *pCLV3* \>\> *GFP* meristems, grown in long days followed by short days.

Fig. S18. WS-4 *pCLV3* \>\> *GFP* meristems, grown in long days.

Fig. S19. WS-4 *pCLV3* \>\> *GFP* meristems, grown in long days followed by short days.

Fig. S20. Example of expression domain variations upon tissue shape changes.

Fig. S21. Meristem size measure versus shape measure.

Fig. S22. Long-range and short-range signals.

Fig. S23. *WUS* sensitivity analysis.

Fig. S24. *CLV3* sensitivity analysis.

Table S1. Example parameter sets.

Movie S1. Primordium growth.
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